Antibodies to apolipoprotein A1 and high density lipoprotein are associated with disease activity in patients with systemic lupus erythematosus

被引：0
|
作者：
O'Neill, S. G. [1 ]
Giles, I. [1 ]
Isenberg, D. A. [1 ]
Rahman, A. [1 ]
机构：
[1] UCL, Div Med, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Antibodies to Apolipoprotein A-I, High-Density Lipoprotein, and C-Reactive Protein Are Associated With Disease Activity in Patients With Systemic Lupus Erythematosus
    O'Neill, Sean G.
    Giles, Ian
    Lambrianides, Anastasia
    Manson, Jessica
    D'Cruz, David
    Schrieber, Leslie
    March, Lyn M.
    Latchman, David S.
    Isenberg, David A.
    Rahman, Anisur
    ARTHRITIS AND RHEUMATISM, 2010, 62 (03): : 845 - 854
  • [2] LOW-LEVELS OF TOTAL CHOLESTEROL, HIGH-DENSITY-LIPOPROTEIN, AND APOLIPOPROTEIN A1 IN ASSOCIATION WITH ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    LAHITA, RG
    RIVKIN, E
    CAVANAGH, I
    ROMANO, P
    ARTHRITIS AND RHEUMATISM, 1993, 36 (11): : 1566 - 1574
  • [3] Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus
    Batuca, J. R.
    Ames, P. R. J.
    Isenberg, D. A.
    Alves, J. Delgado
    AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 : 137 - 146
  • [4] Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
    J Su
    A Cederholm
    E Hurt-Camejo
    E Svenungsson
    J Frostegård
    Arthritis Research & Therapy, 7
  • [5] Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
    Su, J.
    Cederholm, A.
    Hurt-Camejo, E.
    Svenungsson, E.
    Frostegard, J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S40 - S40
  • [6] IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
    Sara Croca
    Paul Bassett
    Sharon Chambers
    Maria Davari
    Karim Fouad Alber
    Oliver Leach
    Yiannis Ioannou
    Ian Giles
    David Isenberg
    Anisur Rahman
    Arthritis Research & Therapy, 17
  • [7] IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
    Croca, Sara
    Bassett, Paul
    Chambers, Sharon
    Davari, Maria
    Alber, Karim Fouad
    Leach, Oliver
    Ioannou, Yiannis
    Giles, Ian
    Isenberg, David
    Rahman, Anisur
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [8] High-density lipoprotein functionality in systemic lupus erythematosus
    Ganjali, Shiva
    Shirmohammadi, Leila
    Read, Morgayn, I
    Sahebkar, Amirhossein
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 769 - 775
  • [9] Antinucleosome antibodies in systemic lupus erythematosus patients: Relation to disease activity and lupus nephritis
    Elessawi, Dina F.
    Mahmoud, Geilan A.
    El-Sawy, Wael S.
    Shieba, Hala F.
    Goda, Shimaa M.
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (01): : 31 - 34
  • [10] Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus
    Aho, K
    Vaarala, O
    Tenkanen, L
    Julkunen, H
    Jouhikainen, T
    Alfthan, G
    Palosuo, T
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (05) : 499 - 506
12345